Behavioral sensitization to beta-phenylethylamine (PEA)

enduring modifications of specific dopaminergic neuron systems in the rat

Toshihide Kuroki, Tetsuyuki Tsutsumi, Makoto Hirano, Takashi Matsumoto, Yoshihiro Tatebayashi, Kohji Nishiyama, Hideyuki Uchimura, Akio Shiraishi, Tatsuo Nakahara, Kaoru Nakamura

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Repeated daily administration of an endogenous trace amine, beta-phenylethylamine (PEA), produces behavioral sensitization such that the intensity of PEA-induced stereotyped behaviors in rats increases gradually during the treatment, and a challenge injection with PEA reinstates the enhanced stereotypy even long after withdrawal. In the present study, we examined the neurochemical changes in the central dopaminergic neuron systems in the rat for 7 drug-free days after repeated treatment with PEA (50 mg/kg, IP day for 14 or 28 days). During withdrawal, a decrease in steady-state levels of tissue dopamine (DA) and its metabolite, dihydroxyphenylacetic acid (DOPAC), was found in the mesolimbic DA nerve terminal areas of the rat brain receiving repeated PEA treatment. Fifteen minutes after challenge administration of PEA at varying doses from 6.3 to 75 mg/kg, the rats with repeated PEA treatment required smaller doses of PEA challenge than the rats with acute PEA treatment in order to obtain a significant decrease in striatal DOPAC content compared to the saline control in each treatment group. These results imply that the behavioral sensitization to PEA is accompanied by enduring modifications of the specific dopaminergic neuron systems in the rat brain. This suggestion was strongly supported by the results of the study using in vivo intracerebral dialysis, which indicated that 25 mg/kg PEA challenge elicited a remarkable increase in the extracellular DA concentrations in striatal perfusates collected from the PEA-pretreated rats, in accordance with the intensity of stereotyped behaviors. These findings argue that the hyper-responsiveness to PEA of the striatal dopaminergic neuron systems persists long after withdrawal from repeated treatment with PEA.

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalPsychopharmacology
Volume102
Issue number1
DOIs
Publication statusPublished - Sep 1 1990
Externally publishedYes

Fingerprint

Phenethylamines
Dopaminergic Neurons
Corpus Striatum
Stereotyped Behavior
Dopamine
phenethylamine
Therapeutics
Acids
Brain
Amines

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Behavioral sensitization to beta-phenylethylamine (PEA) : enduring modifications of specific dopaminergic neuron systems in the rat. / Kuroki, Toshihide; Tsutsumi, Tetsuyuki; Hirano, Makoto; Matsumoto, Takashi; Tatebayashi, Yoshihiro; Nishiyama, Kohji; Uchimura, Hideyuki; Shiraishi, Akio; Nakahara, Tatsuo; Nakamura, Kaoru.

In: Psychopharmacology, Vol. 102, No. 1, 01.09.1990, p. 5-10.

Research output: Contribution to journalArticle

Kuroki, T, Tsutsumi, T, Hirano, M, Matsumoto, T, Tatebayashi, Y, Nishiyama, K, Uchimura, H, Shiraishi, A, Nakahara, T & Nakamura, K 1990, 'Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat', Psychopharmacology, vol. 102, no. 1, pp. 5-10. https://doi.org/10.1007/BF02245736
Kuroki, Toshihide ; Tsutsumi, Tetsuyuki ; Hirano, Makoto ; Matsumoto, Takashi ; Tatebayashi, Yoshihiro ; Nishiyama, Kohji ; Uchimura, Hideyuki ; Shiraishi, Akio ; Nakahara, Tatsuo ; Nakamura, Kaoru. / Behavioral sensitization to beta-phenylethylamine (PEA) : enduring modifications of specific dopaminergic neuron systems in the rat. In: Psychopharmacology. 1990 ; Vol. 102, No. 1. pp. 5-10.
@article{d9330e58096940f08af5b7ca08c7dc19,
title = "Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat",
abstract = "Repeated daily administration of an endogenous trace amine, beta-phenylethylamine (PEA), produces behavioral sensitization such that the intensity of PEA-induced stereotyped behaviors in rats increases gradually during the treatment, and a challenge injection with PEA reinstates the enhanced stereotypy even long after withdrawal. In the present study, we examined the neurochemical changes in the central dopaminergic neuron systems in the rat for 7 drug-free days after repeated treatment with PEA (50 mg/kg, IP day for 14 or 28 days). During withdrawal, a decrease in steady-state levels of tissue dopamine (DA) and its metabolite, dihydroxyphenylacetic acid (DOPAC), was found in the mesolimbic DA nerve terminal areas of the rat brain receiving repeated PEA treatment. Fifteen minutes after challenge administration of PEA at varying doses from 6.3 to 75 mg/kg, the rats with repeated PEA treatment required smaller doses of PEA challenge than the rats with acute PEA treatment in order to obtain a significant decrease in striatal DOPAC content compared to the saline control in each treatment group. These results imply that the behavioral sensitization to PEA is accompanied by enduring modifications of the specific dopaminergic neuron systems in the rat brain. This suggestion was strongly supported by the results of the study using in vivo intracerebral dialysis, which indicated that 25 mg/kg PEA challenge elicited a remarkable increase in the extracellular DA concentrations in striatal perfusates collected from the PEA-pretreated rats, in accordance with the intensity of stereotyped behaviors. These findings argue that the hyper-responsiveness to PEA of the striatal dopaminergic neuron systems persists long after withdrawal from repeated treatment with PEA.",
author = "Toshihide Kuroki and Tetsuyuki Tsutsumi and Makoto Hirano and Takashi Matsumoto and Yoshihiro Tatebayashi and Kohji Nishiyama and Hideyuki Uchimura and Akio Shiraishi and Tatsuo Nakahara and Kaoru Nakamura",
year = "1990",
month = "9",
day = "1",
doi = "10.1007/BF02245736",
language = "English",
volume = "102",
pages = "5--10",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Behavioral sensitization to beta-phenylethylamine (PEA)

T2 - enduring modifications of specific dopaminergic neuron systems in the rat

AU - Kuroki, Toshihide

AU - Tsutsumi, Tetsuyuki

AU - Hirano, Makoto

AU - Matsumoto, Takashi

AU - Tatebayashi, Yoshihiro

AU - Nishiyama, Kohji

AU - Uchimura, Hideyuki

AU - Shiraishi, Akio

AU - Nakahara, Tatsuo

AU - Nakamura, Kaoru

PY - 1990/9/1

Y1 - 1990/9/1

N2 - Repeated daily administration of an endogenous trace amine, beta-phenylethylamine (PEA), produces behavioral sensitization such that the intensity of PEA-induced stereotyped behaviors in rats increases gradually during the treatment, and a challenge injection with PEA reinstates the enhanced stereotypy even long after withdrawal. In the present study, we examined the neurochemical changes in the central dopaminergic neuron systems in the rat for 7 drug-free days after repeated treatment with PEA (50 mg/kg, IP day for 14 or 28 days). During withdrawal, a decrease in steady-state levels of tissue dopamine (DA) and its metabolite, dihydroxyphenylacetic acid (DOPAC), was found in the mesolimbic DA nerve terminal areas of the rat brain receiving repeated PEA treatment. Fifteen minutes after challenge administration of PEA at varying doses from 6.3 to 75 mg/kg, the rats with repeated PEA treatment required smaller doses of PEA challenge than the rats with acute PEA treatment in order to obtain a significant decrease in striatal DOPAC content compared to the saline control in each treatment group. These results imply that the behavioral sensitization to PEA is accompanied by enduring modifications of the specific dopaminergic neuron systems in the rat brain. This suggestion was strongly supported by the results of the study using in vivo intracerebral dialysis, which indicated that 25 mg/kg PEA challenge elicited a remarkable increase in the extracellular DA concentrations in striatal perfusates collected from the PEA-pretreated rats, in accordance with the intensity of stereotyped behaviors. These findings argue that the hyper-responsiveness to PEA of the striatal dopaminergic neuron systems persists long after withdrawal from repeated treatment with PEA.

AB - Repeated daily administration of an endogenous trace amine, beta-phenylethylamine (PEA), produces behavioral sensitization such that the intensity of PEA-induced stereotyped behaviors in rats increases gradually during the treatment, and a challenge injection with PEA reinstates the enhanced stereotypy even long after withdrawal. In the present study, we examined the neurochemical changes in the central dopaminergic neuron systems in the rat for 7 drug-free days after repeated treatment with PEA (50 mg/kg, IP day for 14 or 28 days). During withdrawal, a decrease in steady-state levels of tissue dopamine (DA) and its metabolite, dihydroxyphenylacetic acid (DOPAC), was found in the mesolimbic DA nerve terminal areas of the rat brain receiving repeated PEA treatment. Fifteen minutes after challenge administration of PEA at varying doses from 6.3 to 75 mg/kg, the rats with repeated PEA treatment required smaller doses of PEA challenge than the rats with acute PEA treatment in order to obtain a significant decrease in striatal DOPAC content compared to the saline control in each treatment group. These results imply that the behavioral sensitization to PEA is accompanied by enduring modifications of the specific dopaminergic neuron systems in the rat brain. This suggestion was strongly supported by the results of the study using in vivo intracerebral dialysis, which indicated that 25 mg/kg PEA challenge elicited a remarkable increase in the extracellular DA concentrations in striatal perfusates collected from the PEA-pretreated rats, in accordance with the intensity of stereotyped behaviors. These findings argue that the hyper-responsiveness to PEA of the striatal dopaminergic neuron systems persists long after withdrawal from repeated treatment with PEA.

UR - http://www.scopus.com/inward/record.url?scp=0025287414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025287414&partnerID=8YFLogxK

U2 - 10.1007/BF02245736

DO - 10.1007/BF02245736

M3 - Article

VL - 102

SP - 5

EP - 10

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -